|
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON
DC 20549 CURRENT REPORT
Pursuant to Section 13 or 15 (d) of the Securities Exchange Act of 1934 MEDISCIENCE TECHNOLOGY CORPORATION (EXACT NAME OF REGISTRANT AS SPECIFIED ON CHARTER) NEW JERSEY 0-7405 22-1937826 ____________________________________________________________________________________________________________ (State
of Incorporation)
(Commission File No.)
(IRS Employer Identification No.) 1235 Folkestone Way, P.O. Box 598, Cherry Hill, New Jersey 08003 ____________________________________________________________________________________________________________ Registrant�s telephone number. Including area code (856) 428 7952 ____________________________________________________________________________________________________________ _______________________________________________________________
(Former Address, if changed,
since last report) Item
5. Other Materially Important Events: This disclosure is intended to satisfy: SEC Section 6,
Regulation FD, Section 6.01 Regulation FD Disclosure and Section 7 and 7.0 including all applicable and presently
effective Sarbanes-Oxley disclosure requirements under Regulation G,
additionally posted on Registrants
internet web site
�wwwMedisciencetech.com� see Exhibits �A,B,C� below and Press Release Exhibit
�D� On March 13,2003, By unanimous Board of Directors approval Registrant appointed Michael W. Engelhart as President and Chief Operating Officer effective April 23,2003 (employment contract attached hereto as �Exhibit A.,B,C�) On March 13, 2003 effective April 26, 2003
Mr. Sidney Braginsky, former President COO and the Registrant agreed to the
total and immediate nullification and termination of his July 9,
2001 agreement with Mediscience
Technology Corp. together with all its terms and conditions, including any
claim for accruals in salary and/or expenses effective retroactively as of July
9, 2001. Mr.
Sidney Braginsky will continue as an active Board member, his compensation to
be the same as all other BOD members.
Additionally he will provide compensated consulting services to the
Board and President COO Michael Engelhart as needed. See �Exhibit E�
Employment contract Exhibit �A� Michael W. Engelhart /President/ Chief Operating
Officer
EMPLOYMENT AGREEMENT This
Agreement dated April 23, 2003 by and between Mediscience Technology Corp., a
New Jersey corporation ("MDSC"), 1235 Folkstone Way, Cherry Hill, New
Jersey 08034, and Michael W. Engelhart (ME) ("Employee) residing at 161 North Franklin Turnpike,
Suite 204, Ramsey, NJ 07446
W I
T N E S S E T H: For and in
consideration of the covenants and undertakings set forth below, the parties
hereto hereby agree as follows:
2. The initial term of Employee's employment
hereunder shall commence on April 1st, 2003 or such other date as
shall be mutually acceptable to Employee and the Board of Directors (the
"Board") of MDSC (the "Commencement Date") and shall end on
the third anniversary of the Commencement Date April 23, 2006, said initial
term to be automatically extended by additional one-year renewal terms unless
either MDSC or Employee shall notify the other in writing, at least 30 days
prior to the end of the then current term, of intent to terminate this
Agreement as of the end of the then current term. In addition, this Agreement
is terminable prior to the expiration of its term as above provided in this
Section 2, as follows: (a) by MDSC for Cause (as such term is hereafter defined
in Section 13 and 5 (i), (ii), (iii), (iv), (v) below), and (b) upon the death
or "permanent and total disability" (as such term is defined in
section 22(e)(3) of the Code) of Employee. The term of this Agreement is herein
referred to as the "Term". 3 As President and Chief Operating Officer of MDSC,
Employee shall, subject to the control of the Chairman CEO and Board, have
general charge of the business and affairs of MDSC including any and all
subsidiary companies (e.g. LLC�s) and shall have the direction of all other
officers, agents, consultants, employees of MDSC (except the Chairman of the
Board and Treasurer, who shall report directly to the Board). Employee may assign
such duties to the other officers of MDSC, as he deems appropriate. As President and Chief Operating Officer, Employee
shall, when present, preside at all meetings of the shareholders of MDSC and
shall also preside at all meetings of the Board at which the Chairman of the
Board is not present. Employee shall be ex- officio a member of all committees
of the Board. At the sole discretion of the Chairman/CEO. (Employee may be present and
participate in any meeting of the Board, or any committee or subcommittee
thereof, where a transaction or proposed transaction involving Employee or any
other entity in which Employee has an interest is discussed, evaluated,
considered, or voted upon. Notwithstanding the proceeding, however, Employee
shall not cast a vote in his capacity as officer or director of MDSC with
respect to any transaction involving Employee or any other entity in which
Employee has any interest, direct or indirect. eg THMGroup 4
The Company and �THMLLC group have prepared a comprehensive executive summary/
business plan for the transition of MDSC from a development stage to a
profitable commercial company (the "Business Plan"). The Business
Plan has been reviewed and approved by the Board. Michael Engelhart shall use his best efforts to cause
MDSC to meet the goals and objectives of the Business Plan. 5
In consideration of Employee's services pursuant to this Agreement, during the
Term MDSC shall pay Employee an annual base salary of $ 120,000 (one hundred
and twenty thousand dollars), payable monthly in arrears (with the agreed
exception of a $1,000.00 per month stipend). Annual
base salary and Employee�s exercise of each of the three option rights
(600,000-600,000-600,000) representing Employee�s contract warrant to purchase
a total of 1,800,000 MDSC common shares shall be subject to annual review. The Chairman/CEO reserves the exclusive
right to implement/call for interim Board of Director Review based on the
on-going performance, financial capability of MDSC, and MDSC�s ability to timely
satisfy any of the five critical milestones (each, a "Critical
Milestone") described in the Business Plan (i.e. the completion on budget
of; (i)
Preclinical
toxicity studies within reasonable time of the initial funding contemplated by
the Business Plan (the "Initial Funding Date"), (ii)
Device
development and preclinical validation within a reasonable time period of the
Initial Funding Date
(iii)
Phase
I and II clinical trials within reasonable time of the Initial Funding Date, (iv)
Phase
111 clinical trials and PMA submission to the FDA. (v)
PMA approval within reasonable time of
the Initial Funding Date. In
addition, based on the on- going COO performance, financial capability of
MDSC and timely satisfaction on budget of each Critical Milestone MDSC
board of directors may authorize Employee a cash bonus per year for the timely
achievement on any Critical Milestone either in cash or MDSC common stock at
the election of (ME). In
the event that the Term shall be ended by the death or the permanent and total
disability of Employee, base salary and bonuses shall continue to be paid
during the one-year period following the end of the Term. 6
Employee acknowledges that MDSC does not now have any group life, disability or
medical insurance, or cash bonus, deferred compensation, pension, retirement or
other employee benefit plan of any kind or any liability insurance or director
and officer insurance. Employee agrees that MDSC shall not be required to
institute any of such plans or insurance until and unless its financial
resources permit and then only to the extent contemplated by the Business Plan
except that MDSC shall obtain Directors and Officers Liability Insurance at
the earliest practical time consistent with MDSC�s financial ability to
obtain same. Once instituted in accordance with the Business Plan, Employee
shall be entitled to participate in all such plans and to be covered by all
such insurance. Employee
shall not be entitled to reimbursement for the cost of any insurance Employee
obtains or maintains or for the cost or loss of opportunity to contribute to
any pension or retirement plan, but shall be entitled to a car allowance and
other fringe benefits up to a maximum of $12,000 per year during the Term (in
addition to all fringe benefits required by law to be provided to Employee).
During the Term, Employee shall be entitled to: (i)Vacation
time each year in accordance with MDSC's standard employee policy in respect
thereof from time to time in effect in addition to the holidays normally
observed by MDSC; and (ii)Prompt
reimbursement for reasonable out-of-pocket business expenses incurred by
Employee in accordance with MDSC's standard employee reimbursement policy from
time to time in effect. 7 To the maximum extent permitted by
applicable law, MDSC shall indemnify Employee, and hold Employee harmless from
and against, any loss, damage or claim to which Employee may become subject
as the direct result of any of his acts or omissions as the President and Chief
Operating Officer of MDSC, (including attorneys�
fees, judgments, fines, ERISA excise taxes or penalties and amounts paid in
settlement) reasonably incurred or suffered by Employee in connection therewith
and such indemnification shall continue after has ceased to be a director,
trustee, officer, employee or agent.. MDSC
shall provide at its own expense legal counsel to defend Employee in connection
therewith. Such counsel shall be MDSC's counsel unless MDSC's counsel shall
have a conflict of interest, in which case Employee may select counsel of his
choice and MDSC shall promptly reimburse Employee for the reasonable fees and
expenses of such counsel. The right
to indemnification conferred in this Paragraph 7 shall be a contract right and
shall include the right to be paid by MDSC the expenses (including attorneys�
fees) incurred by Employee in defending any such legal proceeding in advance of
its final disposition. Employee
understands, as his additional contract obligation and as a MTC contract right
that it will be an irreparable material breach of his employment agreement
should employee not fully cooperate, individually or through counsel in any legal action whatsoever where any loss, damage or claim asserted is claimed to be the direct or indirect result of any of his acts or omissions as the President and Chief Operating Officer of MDSC. Employee herein acknowledgeshis contractual obligation for his unqualified cooperation so as to enable Mediscience to mitigate, defend, settle, and otherwise resolve any matter in the best interest of the Company�s shareholders, investors and management. 8
During the Term, Employee shall devote his time and energies to the business of
MDSC. Notwithstanding the foregoing and provided that such activities do not
materially impair the performance by Employee of his duties under this
Agreement as President and Chief Operating Officer of MDSC, Employee shall not
be prohibited from: (i)
Engaging
in charitable and civic activities, (ii)
Discharging
those obligations which Employee is subject to on the date of this Agreement as
summarized on his Annex I hereto (iii)
Continuing
to participate in those businesses/boards listed on Annex 1 hereto ( (iv)
Retaining
for his personal benefits all fees, honoraria and profits from the activities
permitted by clauses (i), (ii) and (iii) of this sentence. 9
The Board has adopted an incentive stock option plan (the " 1999
Plan") complying with section 422 of the Internal Revenue Code of 1986, as
amended (the "Code"), and will recommend the 1999 Plan to MDSC's
shareholders for their approval at the next annual meeting of shareholders of
MDSC which will take place within a reasonable time, subject to financial
resource ability, after the date of the Board's adoption of the 1999 Plan. The
1999 Plan permits holders of options granted there-under to pay the exercise
price due upon their exercise of such options either with cash or shares of
MDSC Common Stock valued at the fair market value of such shares at the time of
such exercise. The 1999 Plan will provide for the maximum periods permitted by
the Code during which the Option can be exercised following the death,
permanent and total disability or termination of employment. 10.
On the date of this Agreement, MDSC will for $100.00 dollars grant to Employee
an incentive stock option / Warrant pursuant to the 1999 Plan (the
"Option") to purchase a total of 2,000,000 shares of MDSC common
stock: (i)
1,800,000
shares of MDSC common stock at the option price of $1.00 per share (ii)
200,00
shares of MDSC common stock at the option price of $.025 cents per share (i)
(ME)
shall have the unqualified right to assign NO MORE than 50% (fifty percent) his
warrant rights subject to all contract terms and restrictions contained in
this agreement and contained in the language of the warrant or warrants. See controlling paragraph 11 This
option shall be effected as to any and all adjustment in the event of any
funding, stock splits, reverse stock splits, warrants, etc, excepting however
contract rights, agreements anti-dilution rights, etc (reflected in corporate SEC filings) in Peter Katevatis Esq.
and Dr. Robert Alfano founders.
The
option of 1,800,000 shares will be exercisable subject to the following
conditions precedent for each proposed exercise: a)
To the extent of 600,000 shares from and after the later of: (i) the date on
which MDSC and /or any wholly owned subsidiary company shall have received at
least $5.0 (five) million in
equity investments based upon the Business Plan This provision can not under
any circumstances or reason be independently waived by Board of Directors
action. Chairman/CEO at his sole
discretion and authority can introduce a motion for total or partial waiver to
the Board of Directors based on the on- going COO performance, financial
capability of MDSC and timely satisfaction on budget of each Critical
Milestone. (b)
To the extent of an additional 600,000 shares from and after the later of (ii) the date on which MDSC shall
have received a total of at least $ 10 (ten) million. In equity investments
based upon the Business Plan. This
provision cannot under any circumstances or reason be independently waived by
Board of Directors action.
Chairman/CEO at his sole discretion and authority can introduce a motion
for total or partial waiver to the Board of Directors based on the on- going
COO performance, financial capability of MDSC and timely satisfaction on budget
of each Critical Milestone c)
To the extent of an additional 600,000 shares from and after (iii) the date on which MDSC
shall have received at least $ 15 (fifteen) million in equity investments based
upon the Business Plan. This provision cannot under any circumstances or reason
be independently waived by Board of Directors action. Chairman/CEO at his sole discretion and authority may
introduce a motion for total or partial waiver to the Board of Directors based
on the on- going COO performance, financial capability of MDSC and timely
satisfaction on budget of each Critical Milestone Notwithstanding
the foregoing provisions of this Section 10, the total Option will be fully
exercisable in the event of a "change in control" brought about
through the direct and material efforts of employee President COO Michael
Engelhart and directly resulting from the sale, transfer or disposition of all
or substantially all of the assets of MDSC for approved value, a merger for
approved value involving MDSC in which a majority of the Board of Directors of
the surviving entity is not composed of members of the Board of MDSC as of the
day preceding the effective date of the merger, or the leveraged buyout of MDSC
for approved value (a "Change in Control"). The
Option, in total or remaining, will expire on the fifteenth anniversary of the
date of this Agreement. 11.
The Warrant and the Option will bear a legend to the effect that the Warrant or
Option, as the case may be, and the shares of Common Stock of MDSC to be issued
upon exercise thereof (respectively, the "Option Shares" and the
"Warrant Shares") have not been registered under the Securities Act
of 1933 (the "Act") or the Blue Sky laws of any jurisdiction (the
"Blue Sky Laws"), that the Warrant and the Option have been, and if
issued the Warrant Shares and the Option Shares will be, acquired by Employee
for investment, pursuant to the terms of this employment agreement incorporated
herein as part of the warrant and that neither the Warrant nor the Option
nor the Warrant Shares nor the Option Shares may be sold, transferred, pledged
or hypothecated in the absence of an effective registration statement for the
Warrant and/or the Warrant Shares or the Option and/or the Option Shares, as
the case may be, under the Act and the Blue Sky Laws or an opinion of counsel
to MDSC that registration is not required under the Act or the Blue Sky Laws. There
are two types of options available, qualified and nonqualified. At this time,
the company does not know if the above options when exercised in the future
will be taxable. Therefore: (i)It
is understood and agreed to by the parties to this agreement that any options
exercised in the future by any officer or director are determined and agreed by
the parties herein as taxable, unless the Company prior to the exercise of the
warrant shall receives an IRS opinion to the contrary. The Company will discuss with the
IRS and appropriate Department of Taxation and Finance to establish the amount
of any liability. (ii)The
selling individuals will be responsible and pay any and all such tax. The
selling warrant. /option holder will provide affidavit certification thereof
from his selling broker that the selling brokerage firm has paid and forwarded
all appropriate tax payments as a condition precedent to any cash or share
distribution to the selling warrant/option holder. (iii)Companies
are required by law to withhold taxes where they are due this tax payment
obligation is by agreement incorporated as a material term of the issuing
warrant/option and is intended to establish Mediscience as a third party
contract beneficiary to the broker/client share sale agreement thus assuring
the tax payment and avoiding any and all tax liability. in the Company or its
Board of Directors. (iv)The
rules of limited liability protect directors of a company from most corporate
mismanagement. They do not, however, apply to failure to pay taxes. 12.
In the event that Employee voluntarily terminates his employment or Employee's
employment is terminated by MDSC for Cause, Employee shall be entitled to
receive compensation and benefits earned by him and/or accruing to him prior to
the date of such termination, prorated up to and including such date. In
the event that Employee's employment is terminated by MDSC without Cause or in
connection with a Change in Control, Employee shall be entitled to receive
compensation and benefits earned by him and/or accruing to him prior to the
date of such termination, prorated up to and including the first anniversary of
such date or, if longer, until the scheduled expiration date of the Term. For
purposes of this Agreement, "Cause" means any of the following: (i)
any act or acts of Employee constituting a felony (or its equivalent) under the
laws of the United States, any state thereof or any foreign jurisdiction; or
(ii) any material breach by Employee of this Agreement or the policies of MDSC
or any of its subsidiaries or the willful and persistent (after written notice
to Employee) failure or refusal of Employee to perform his duties of employment
or comply in any material respect with any lawful directives of the Board
and/or Chairman CEO; or (iii) a course of conduct by Employee amounting to
gross neglect, willful misconduct or dishonesty; or (iv) any misappropriation
of material property (whether real, personal, tangible or intangible) of MDSC
by Employee; or (v) any misappropriation of a corporate or business opportunity
of MDSC or any of its subsidiaries by Employee. Anything to the contrary herein
notwithstanding, " "Cause" shall include Employee's
failure or inability to materially meet or cause MDSC to materially meet the
particular performance goals or targets set out in Paragraph 5 (i), (ii),
(iii), (iv), (v). 13.
During Employee's employment by MDSC and during any time thereafter while
Employee remains a member of the Board or a consultant to MDSC, he will develop
and be exposed to confidential information and trade secrets of MDSC as well as
similar information which MDSC has received from others (e.g. Sarnoff
Corporation, Drexel University, Hahanemann and CUNY) and considers to be
confidential. Employee understands that the maintenance of the proprietary
character of such information is vital to MDSC. Accordingly, at any time during
Employee's employment and at all times thereafter, he will not disclose to
others any such confidential information or trade secrets. The provisions of
this Section 14 shall not apply after the proprietary information has been: (i)
voluntarily disclosed to the public by MDSC; or (ii) independently developed
and disclosed by others; or (iii) otherwise enters the public domain through
lawful means. 14.
For an 18-month period following the termination of his employment under the
terms of Section 2 above, Employee shall not for his account or in any other
capacity (including as an officer, member, employee, consultant, partner,
representative, sole proprietor or advisor of another) participate in any
entity (or affiliate or connect with, or render service to, or furnish
assistance or advice to, any person, corporation, firm or other organization),
which, in competition with MDSC, (a) renders medical services or engages in
research, development, marketing and/or manufacture of medical devices or
equipment or (b) utilizes optical spectroscopy methods and instrumentation to:
(i) differentiate dysplastic or malignant from nonmalignant tissue and cellular
smears; (ii) determine the efficacy of vitamins and/or and other chemicals in
reversing pre-cancerous conditions; (iii) differentiate between sterile and
non-sterile environments; (iv) differentiate between residue and non-residue
environments; (v) create images in turbid media using time and space gated
technology for optical mammography and tomography; or (vi) determine healing
from sores, wounds and burns. Without limiting MDSC's other remedies, in the
event of Employee's actual or threatened breach of this Section 15, MDSC shall
be entitled to injunctive relief to enforce it. 15.
This Agreement shall inure to and be binding on the successors and assigns of
MDSC. This Agreement contemplates personal services and shall not be assignable
by Employee. 16.
This Agreement supersedes in its entirety all other agreements and understandings,
both written and oral, regarding Employee's employment with MDSC. 17.
Unless otherwise hereinafter designated by either party, any notices or written
communications under this Agreement shall be faxed and confirmed by certified
mail to the parties herein. 18.
This Agreement, the Option and the Warrant contain the entire understanding and
agreement between the parties with respect to the subject matter hereof and
thereof. The
invalidity and/or failure to materially perform by Employee (ME) of his contract
obligations under paragraph 5 (i), (ii), (iii), (iv), (v) will render this
agreement null and void in full or in part modified to the extent of Employees
proportional failure to perform.
Otherwise
the invalidity of any other provision of this Agreement shall not impair the
validity of any remaining provision. All parties to this agreement shall use
diligence and good faith effort to satisfy any and all time requirements e.g.
FDA applicable law etc. In this respect time is not of the essence to this
agreement, performance is (see Paragraph 5). Any
representations, promises or conditions in connection therewith not
incorporated herein, in the Option or in the Warrant shall not be binding upon
either party. No modification, waiver or agreement of termination of this
Agreement shall be binding upon either party unless made in writing and signed
for or on behalf of such party. 19.
This Agreement shall be construed in accordance with the laws of the State of
New Jersey and MDSC and Employee hereby agree to submit any and all disputes to
binding arbitration before a single independent knowledgeable and industry
qualified arbitrator in New Jersey with the American Arbitration Association,
and pursuant to the American Arbitration Association�s then-applicable rules
and procedures. IN
WITNESS WHEREOF, the parties intending to be legally bound have executed this
Agreement on and as of the date first above written. MEDISCIENCE
TECHNOLOGY CORP. April 23,2003 By:
Peter Katevatis Esq. Chairman of the Board / Chief Executive Officer
SS:
PK By: Michael W. Engelhart April 17, 2003 SS:
ME I, Peter Katevatis Esq. Chairman/CEO herein acknowledge
the receipt of $100.00 from Michael W. Engelhart in satisfaction of his right
to purchase Mediscience Technology Warrant more properly described in
paragraphs. 10. And 11 of this agreement �On the date of this Agreement, MDSC
will for $100.00 dollars grant to Employee an incentive stock option / Warrant
pursuant to the 1999 Plan (the "Option") to purchase a total of
2,000,000 shares of MDSC common stock:� under the terms and conditions
contained herein. SS:
By: PK Chairman/CEO April 23, 2003
Authorized by BOD minutes March 13,2003
CONTRACT
WARRANT TO PURCHASE COMMON STOCK
OF MEDISCIENCE TECHNOLOGY CORP. (MTC)
DATE: April 23, 2003 Exhibit �B� The
agreement dated April 23, 2003 between Michael W. Engelhart (ME) and
Mediscience Technology Corp. (MDSC) establishing his employment as President,
Chief Operating Officer is incorporated, controlling herein, attached and made
a part hereof as �Exhibit A� (MDSC)
herein grants a qualified three (3) year warrant in (ME) to purchase a total of
200,000 Mediscience Common shares restricted and leg ended SEC rule 144 at
$.025 cents All shares to be
issued by Mediscience Technology Corp. a corporation organized and existing
under the laws of the State of New Jersey Term
of this Contract warrant: April 23, 2003 to April 23, 2006, It is understood
that this time period may be extended by future written Board of Director
action to be incorporated and a part hereof as an attachment. This warrant shall NOT be effected as to any and all
adjustment in the event of any funding, stock splits, reverse stock splits,
warrants, etc, including all
contract rights, agreements anti-dilution rights, etc (reflected in corporate SEC filings and (MTC) employment
agreements) in Peter Katevatis Esq. and Dr. Robert Alfano founders. This warrant bears a legend to the
effect that the warrant, and any shares of Common Stock of MDSC to be issued
upon proper exercise thereof (respectively, the "Option Shares�) have not
been registered under the Securities Act of 1933 (the "Act") or the Blue
Sky laws of any jurisdiction (the "Blue Sky Laws"), and if issued the
Option Shares will be, acquired by Employee for investment, pursuant to the
terms of this employment agreement incorporated herein (Exhibit A). Further that neither the
warrant nor the Option Shares may be sold, transferred, pledged or hypothecated
in the absence of an effective registration statement for the warrant and/or
the Option Shares, as the case may be, under the Act and the Blue Sky Laws or
an opinion of counsel to MDSC that registration is not required under the Act
or the Blue Sky Laws, except to the extent allowable by law. This
warrant Board Approved: March 13,
2003 NYC Minutes of Meeting incorporated by reference Issuer: Mediscience Technology Corporation Cherry
Hill New Jersey 1.Exercise, issuance of certificates: Payment for Shares: ---The rights
represented by this warrant when properly exercised in whole or in part by (ME)
will be effected by tender of this warrant in whole or in part at the principle
office of (MTC) 1235 Folkstone Way Cherry Hill NJ 08034, with payment to
(MTC) by certified check for the purchase price for such shares. All shares
shall be issued to (ME) per his written instructions as designated record owner
as of the close of business when Warrant and payment has been received by
(MTC).The selling individual (ME) will be solely responsible for and pay any
and all Federal/State taxes. The selling warrant holder (ME) must provide
affidavit certification thereof
that he has paid and is solely responsible for all appropriate tax
payments. as a condition precedent to any issuance of the shares. 2. Shares
to be fully paid; Reservation of Shares: --- (MTC) covenants and agrees: a. That during the Warrant
exercise period, (MTC) will take all such action as may be necessary to assure
that the Common Stock assumable upon the exercise hereof may be so issued
without violation of any applicable law. b. That during the Warrant exercise
period, (MTC) will at all times use its best efforts to have authorized, and
reserved for the purpose of issue or transfer upon exercise of (ME) warrant rights, a sufficient
number of shares of Common Stock to provide for the rights represented by this
Warrant 3.
Mediscience Technology (MTC) certifies that this three year warrant is issued
to Michael W. Engelhart residing at 161 North Franklin Turnpike, Suite 204,
Ramsey, NJ 07446 as part of the consideration exchanged in the execution of his
employment agreement as President Chief Operating Officer of (MDSC) dated April
23, 2003 (see
MTC/ ME Exhibit A contract terms). IN
WITNESS WHEREOF, (MTC) by authority of its Board of Directors March 13, 2003
has caused this warrant to be signed by its duly authorized officer as of April
23, 2003 MEDISCIENCE TECHNOLOGY CORP.By, _ss signature 4-23-03____________________________
Peter Katevatis, Chairman of The Board
CONTRACT WARRANT TO PURCHASE COMMON STOCK OF MEDISCIENCE TECHNOLOGY CORP. (MT
DATE:
April 23, 2003 Exhibit �C� The
agreement dated April 23, 2003 between Michael W. Engelhart (ME) and
Mediscience Technology Corp. (MDSC) establishing his employment as President,
Chief Operating Officer is incorporated, controlling herein, attached and made
a part hereof as �Exhibit A� (MDSC)
herein grants a qualified three (3) year warrant in (ME) to purchase a total of
1,800,000 Mediscience Common shares restricted and leg ended SEC rule 144 at
$1.00 per share in three milestone contract stages of 600,000-600,000-600,000
shares. All shares to be issued by Mediscience Technology Corp. a corporation
organized and existing under the laws of the State of New Jersey Term
of this Contract warrant: April 23, 2003 to April 23, 2006, It is understood
that this time period may be extended by future written Board of Director
action to be incorporated and a part hereof as an attachment. This warrant shall be effected as to any and all adjustment
in the event of any funding, stock splits, reverse stock splits, warrants, etc,
excepting however all contract rights, agreements anti-dilution rights,
etc (reflected in corporate SEC
filings and (MTC) employment agreements) in Peter Katevatis Esq. and Dr. Robert
Alfano founders. This warrant bears a legend to the
effect that the warrant, and any shares of Common Stock of MDSC to be issued
upon proper exercise thereof (respectively, the "Option Shares�) have not
been registered under the Securities Act of 1933 (the "Act") or the
Blue Sky laws of any jurisdiction (the "Blue Sky Laws"), and if
issued the Option Shares will be, acquired by Employee for investment, pursuant
to the terms of this employment agreement incorporated herein (Exhibit A). Further that neither the
warrant nor the Option Shares may be sold, transferred, pledged or hypothecated
in the absence of an effective registration statement for the warrant and/or
the Option Shares, as the case may be, under the Act and the Blue Sky Laws or
an opinion of counsel to MDSC that registration is not required under the Act
or the Blue Sky Laws, except to the extent allowable by law. This warrant Board Approved: March 13, 2003 NYC Minutes of Meeting
incorporated by reference Issuer:
Mediscience Technology Corporation Cherry Hill New Jersey. Corporate Milestone satisfaction
may be totally or partially satisfied in either of two alternatives by (ME):
A. Satisfaction of Paragraph 5 milestones (ME), predicated on his meeting contract
milestones (paragraph 5 (i), (ii), (iii), (iv), (v) Exhibit A) during the three
year period (April 23, 2003 to April 23, 2006) is entitled to purchase from
Mediscience Technology Corp. (MTC), at the price of one dollar ($1.00) per share up to one million
eight hundred thousand (1,800,000) of (MTC) common. �Exhibit A� Said purchases
to be seriatim milestone approved by Board of Director action.
B. Funding of $ 5M
$10M $15M The
warrant of 1,800,000 shares will be exercisable subject to the following
conditions precedent a)
To the extent of 600,000 shares from and after the later of: (i) the date on
which MDSC and /or any wholly owned subsidiary company shall have received at
least $5.0 (five) million in equity
investments based upon the Business Plan This provision can not under any
circumstances or reason be independently waived by Board of Directors
action. Chairman/CEO at his sole
discretion and authority can introduce a motion for total or partial waiver to
the Board of Directors based on the on- going COO performance, financial
capability of MDSC and timely satisfaction on budget of each Critical
Milestone. (b)
To the extent of an additional 600,000 shares from and after the later of (ii) the date on which MDSC shall
have received a total of at least $ 10 (ten) million. In equity investments
based upon the Business Plan. This
provision cannot under any circumstances or reason be independently waived by
Board of Directors action.
Chairman/CEO at his sole discretion and authority can introduce a motion
for total or partial waiver to the Board of Directors based on the on- going
COO performance, financial capability of MDSC and timely satisfaction on budget
of each Critical Milestone c)
To the extent of an additional 600,000 shares from and after (iii) the date on which MDSC
shall have received at least $ 15 (fifteen) million in equity investments based
upon the Business Plan. This provision cannot under any circumstances or reason
be independently waived by Board of Directors action. Chairman/CEO at his sole discretion and authority may
introduce a motion for total or partial waiver to the Board of Directors based
on the on- going COO performance, financial capability of MDSC and timely
satisfaction on budget of each Critical Milestone All shares will be forwarded to (ME)
to 161 North Franklin Turnpike, Suite 204, and Ramsey, NJ 07446
Attention Michael W. Engelhart (MTC)
reserves the right to cancel this three (3) year warrant in whole or in part at
any time during the three-year period in accordance with Exhibit A terms and
conditions. Thus avoiding the
issuance of all or the remaining unissued the shares. Notwithstanding the foregoing provisions
of this warrant it will be fully exercisable in the event of a �change in
control� for value which occurs on or prior to the warrant expiration date and
which results from the sale, transfer or disposition of all or substantially
all of the assets of (MTC), a merger involving (MTC) in which a majority of the
Board of Directors of the surviving entity is not composed of members of the
Board of directors as of the day preceding the effective date of the merger, or
the leveraged buyout of (MTC) (�a change in control�). See Exhibit A applicable
terms. 1.Exercise,
issuance of certificates: Payment for Shares: ---The rights represented by this
warrant when properly exercised in whole or in part by (ME) will be effected by
tender of this warrant in whole or in part at the principle office of (MTC) 1235
Folkstone Way Cherry Hill NJ 08034, with payment to (MTC) by certified check
for the purchase price for such shares. All shares shall be issued to (ME)
per his written instructions as designated record owner as of the close of
business when Warrant and payment has been received by (MTC). The selling individual (ME) will be solely
responsible for and pay any and all Federal/State taxes. The selling warrant holder (ME) must provide
affidavit certification thereof from his selling broker that the selling
brokerage firm has paid and forwarded all appropriate tax payments as a
condition precedent to any cash or share distribution to the selling
warrant/option holder.
2. Shares to be fully paid; Reservation of Shares: --- (MTC) covenants and agrees: a. That during the Warrant
exercise period, (MTC) will take all such action as may be necessary to assure
that the Common Stock assumable upon the exercise hereof may be so issued
without violation of any applicable law. b. That during the Warrant exercise
period, (MTC) will at all times use its best efforts to have authorized, and
reserved for the purpose of issue or transfer upon exercise of (ME) warrant rights, a sufficient
number of shares of Common Stock to provide for the rights represented by this
Warrant. 3. Mediscience Technology (MTC)
certifies that this three year warrant is issued to Michael W. Engelhart
residing at 161 North Franklin Turnpike, Suite 204, Ramsey, NJ 07446 for value
received of one hundred dollars $100.00 (see MTC/ ME Exhibit A contract terms).
__ss:
Signature_SS:PK______________________________________ Peter
Katevatis President/CEO April 23, 2003 IN
WITNESS WHEREOF, (MTC) by authority of its Board of Directors has caused
this warrant to be signed by
its duly authorized officer as of April 23, 2003 MEDISCIENCE TECHNOLOGY CORP.By, ss: signature April 23, 2003 Peter
Katevatis, Chairman of The Board Press Release Exhibit �D� Distribution Biz Wire BioMed 4-29-03 7AM To Read Click Here
�Exhibit E� Braginsky Affadavit I
Sidney Braginsky, herein agree to the total and immediate nullification and
termination of my executory agreement with Mediscience Technology Corp. dated
July 9, 2001 together with
all its terms and conditions, including any claim for accruals in salary and/or
expenses effective retroactively as of July 9th 2001 THIS
HOLD HARMLESS AGREEMENT by Mediscience Technology Corp. incorporated herein and
made a part hereof: Mediscience
Technology Corp. (MDSC) shall hold Sidney Braginsky harmless from any and all
claims, actions, injuries, proceedings, expenses, damages, statutory or other
fines, levy�s, taxes (state/federal) of whatsoever nature domestic or foreign
and all liabilities including but not limited to, reasonable attorney fees and
court costs arising from Mediscience Technology Corp. negligence, willful
misconduct, or breach of its obligations enumerated hereunder.
SS: PK
______________________________
Peter Katevatis Esq. Chairman/CEO April 26, 2003
Authorized by BOD meeting March
13, 2003 NYC Mr.
Sidney Braginsky shall continue as a Board member, his compensation to be the same as all other BOD
members. Additionally he will
provide compensated consulting services to the Board and President COO Michael
Engelhart as needed. By
our signatures below we waive any and all rights and or claims that exist or
may exist between us by virtue of or arising out of our executory attempted COO
employment agreement dated July 9, 2001.
SS:
SB________________
SS: PK_________________________- Sidney
Braginsky Date: April 26,2003
Peter Katevatis Esq. Date
April 26,2003 Chairman/CEO
Mediscience Technology Corp. President
Digilab Inc.
Per: BOD Meeting 3-13-2003 NYC
SIGNATURES Pursuant to the requirements of the Securities and Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized MEDISCIENCE TECHNOLOGY CORPORATION
____________________ss/Peter Katevatis ________________________
Peter Katevatis, Chairman/CEO Dated April 28, 2003 |